A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: improbable (1), doubtful (8), not likely (447)

Dabrafenib Ver 1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for the first line tr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Methotrexate ver 1

Description
Chemotherapy Protocol HEAD AND NECK CANCER METHOTREXATE Regimen Head and Neck Cancer – Methotrexate Indication Advanced head and nec
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Methotrexate-ver-1.pdf

Cisplatin (100)-Radiotherapy

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (100) RT Regimen Head and Neck Cancer – Cisplatin (100) RT Indication Radical treatment o
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin100-Radiotherapy.pdf

Cisplatin (100) RT (21 day)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (100) RT (21 day) Regimen Head and Neck Cancer – Cisplatin (100) RT (21 day) Indication R
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-100-RT-21-day.pdf

HSCTRituximab_100mg-7day

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT RITUXIMAB 100mg (Weekly) Regimen • HSCT Allograft - Rituximab (7 day-100mg) Indications • EB
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTRituximab-100mg-7day.pdf

Pentostatin

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA PENTOSTATIN Regimen • HCL – Pentostatin Indication • Hairy cell leukaemia Toxicity Drug Pentostat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/Pentostatin.pdf

CladribineSC

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA CLADRIBINE (SC) Regimen • HCL – Cladribine (SC) Indication • Hairy cell leukemia Toxicity Drug Cladribi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/CladribineSC.pdf

CladribineIV

Description
Chemotherapy Protocol HAIRY CELL LEUKEMIA CLADRIBINE (IV-5 day) Regimen • HCL – Cladribine (IV-5 day) Indication • Hairy cell leukaemia (this is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/HCL/CladribineIV.pdf

Bevacizumab ver 1

Description
Chemotherapy Protocol CNS CANCER BEVACIZUMAB This protocol may require funding. This is an unlicensed indication for bevacizumab. Regimen CNS-Bev
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Bevacizumab-ver-1.pdf

Eribulin

Description
Chemotherapy Protocol BREAST CANCER ERIBULIN Regimen • Breast Cancer – Eribulin Indication • Treatment of locally advanced or meta
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEribulinVer1.2.pdf
61 to 70 of 494
Previous … 5 6 7 8 9 … Next